Journal Information
Vol. 45. Issue S4.
HEMO 2023
Pages S683 (October 2023)
Share
Share
Download PDF
More article options
Vol. 45. Issue S4.
HEMO 2023
Pages S683 (October 2023)
Full text access
APPLIED MUSCLE TENSION FOR REDUCING BLOOD DONOR VASOVAGAL REACTIONS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Visits
230
JM Ganema, PGLB Borgesa, JPR Oliveirab, MEDDSPE Silvaa, JPMRJ Silvac, ALM Britod, ICR Diogod, JVFA Cordeirod
a Escola de Medicina Souza Marques (FTESM), Rio de Janeiro, RJ, Brazil
b Faculdade Israelita de Ciências da Saúde Albert Einstein (FICSAE), São Paulo, SP, Brazil
c Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, RJ, Brazil
d Universidade Federal do Estado do Rio de Janeiro (UNIRIO), Rio de Janeiro, RJ, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 45. Issue S4

HEMO 2023

More info
Introduction/objectives

Vasovagal reactions (VVR) are an important adverse effect following phlebotomy that has been increasingly associated with donor lapse from subsequent donation. Applied Muscle Tension (AMT) is seen as a means to mitigate this risk of said reactions by temporarily increasing blood pressure during donation through repetitive tension of major muscles. This meta-analysis aims to evaluate AMT's effectiveness in preventing vasovagal reactions among blood donors through number of events and Blood Donation Reactions Inventory (BDRI) scale, which evaluates 11 prevalent symptoms associated with blood donation on a scale ranging from 0 to 5.

Methods

The databases PubMed, Scopus, Embase, Web of Science and Cochrane were searched for relevant abstracts published until August 2023. The search yielded 111 original papers following duplicate removal. Results were screened for randomized clinical trials relevant to the theme of this review. Two independent and blind reviewers participated in each step of the article selection with a third reviewer to solve any conflicts, in accordance with PRISMA guidelines.

Results

Three randomized trials, involving 500 participants in the AMT group and 496 participants in the control group, were included. A random effects analysis yielded a pooled risk ratio of 0.51 (95% CI: 0.37 - 0.69) (Z = 4.25, p < 0.0001) for vasovagal reactions in the AMT group compared to the control group. Additionally, the studies demonstrated low heterogeneity (I² = 0%), indicating consistency in effect sizes. A subsequent mean difference analysis was conducted based on four papers which evaluated BDRI scores establishing a 0.14 difference favoring intervention (95% CI: 0.08 - 0.21).

Discussion

The meta-analysis findings support AMT as an effective intervention for reducing vasovagal reactions among blood donors with a Number Needed to Treat of 12. Given the well-established role of Vasovagal Reactions as deterrents to subsequent donation among blood donors, implementation of said strategies may prove to be a valuable tool in preventing donor lapse. The consistency of effect sizes, evidenced by low heterogeneity (I² = 0%), further strengthens the validity of the pooled results. However, limitations such as the small number of studies and differences in intervention protocols and outcome measures warrant cautious interpretation.

Conclusion

This meta-analysis establishes AMT as an effective approach for reducing vasovagal reactions during blood donation. The intervention may enhance the donor's overall experience and potentially increase donor retention rates. Further research is needed to explore long-term effects and optimize AMT's integration into blood donation practices.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools